» Articles » PMID: 35946425

Differential Requirement for DICER1 Activity During the Development of Mitral and Tricuspid Valves

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2022 Aug 10
PMID 35946425
Authors
Affiliations
Soon will be listed here.
Abstract

Mitral and tricuspid valves are essential for unidirectional blood flow in the heart. They are derived from similar cell sources, and yet congenital dysplasia affecting both valves is clinically rare, suggesting the presence of differential regulatory mechanisms underlying their development. Here, we specifically inactivated Dicer1 in the endocardium during cardiogenesis and found that Dicer1 deletion caused congenital mitral valve stenosis and regurgitation, whereas it had no impact on other valves. We showed that hyperplastic mitral valves were caused by abnormal condensation and extracellular matrix (ECM) remodeling. Our single-cell RNA sequencing analysis revealed impaired maturation of mesenchymal cells and abnormal expression of ECM genes in mutant mitral valves. Furthermore, expression of a set of miRNAs that target ECM genes was significantly lower in tricuspid valves compared to mitral valves, consistent with the idea that the miRNAs are differentially required for mitral and tricuspid valve development. We thus reveal miRNA-mediated gene regulation as a novel molecular mechanism that differentially regulates mitral and tricuspid valve development, thereby enhancing our understanding of the non-association of inborn mitral and tricuspid dysplasia observed clinically.

Citing Articles

Amniotic membrane, a novel bioscaffold in cardiac diseases: from mechanism to applications.

Rayat Pisheh H, Darvishi A, Masoomkhah S Front Bioeng Biotechnol. 2025; 12:1521462.

PMID: 39758951 PMC: 11696288. DOI: 10.3389/fbioe.2024.1521462.


Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease.

Song M, Wang H, Liu C, Jin S, Liu B, Sun W Front Pharmacol. 2024; 15:1348280.

PMID: 38698813 PMC: 11063341. DOI: 10.3389/fphar.2024.1348280.

References
1.
Bartram U, Bartelings M, Kramer H, Gittenberger-de Groot A . Congenital polyvalvular disease: a review. Pediatr Cardiol. 2001; 22(2):93-101. DOI: 10.1007/s002460010169. View

2.
Ellesoe S, Workman C, Bouvagnet P, Loffredo C, McBride K, Hinton R . Familial co-occurrence of congenital heart defects follows distinct patterns. Eur Heart J. 2017; 39(12):1015-1022. PMC: 6018923. DOI: 10.1093/eurheartj/ehx314. View

3.
Kodigepalli K, Thatcher K, West T, Howsmon D, Schoen F, Sacks M . Biology and Biomechanics of the Heart Valve Extracellular Matrix. J Cardiovasc Dev Dis. 2020; 7(4). PMC: 7765611. DOI: 10.3390/jcdd7040057. View

4.
Lin C, Lin C, Chen C, Zhou B, Chang C . Partitioning the heart: mechanisms of cardiac septation and valve development. Development. 2012; 139(18):3277-99. PMC: 3424040. DOI: 10.1242/dev.063495. View

5.
ODonnell A, Yutzey K . Mechanisms of heart valve development and disease. Development. 2020; 147(13). PMC: 7338271. DOI: 10.1242/dev.183020. View